Table 3.
Correlation test results in type 2 diabetes patients.
| Mean ADC values | ||||
|---|---|---|---|---|
| Both kidneys’ | Pancreas | |||
| Mean ADC values | Both kidneys’ | r | –0.002 | |
| pa | 0.99 | |||
| Pancreas | r | –0.002 | ||
| pa | 0.99 | |||
| Sex | r | 0.109 | –0.263 | |
| pb | 0.503 | 0.101 | ||
| Age, years | r | –0.394 | 0.368 | |
| pa | 0.012 | 0.02 | ||
| Hb1Ac, % | r | 0.170 | 0.397 | |
| pa | 0.294 | 0.011 | ||
| eGFR, mL/min | r | 0.448 | 0.071 | |
| pa | 0.004 | 0.663 | ||
| Creatinine, mg/dL | r | –0.324 | –0.137 | |
| pa | 0.041 | 0.4 | ||
| Treatment, code 1/2/3 | r | 0.109 | 0.446 | |
| pb | 0.501 | 0.004 | ||
| Duration of disease, years | r | –0.344 | 0.527 | |
| pa | 0.03 | 0.000 | ||
ADC, apparent diffusion coefficient. Code 1: male, Code 2: female. y. HbA1c: glycated hemoglobin, eGFR: estimated glomerular filtration rate. Treatment codes, code 1: only oral antidiabetic; code 2: oral antidiabetic + insulin; code 3: only insulin.ap-value shows the results of Pearson’s correlation test.bp-value shows the results of Spearman’s correlation rho efficient test.